Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Involvement of the L-Type Amino Acid Transporter Lat2 in the Transport of 3,3'-Diiodothyronine across the Plasma Membrane.
Kinne A
,
Wittner M
,
Wirth EK
,
Hinz KM
,
Schülein R
,
Köhrle J
,
Krause G
.
???displayArticle.abstract???
Thyroid hormones are transported across cell membranes by transmembrane transporter proteins, for example by members of the monocarboxylate transporter (MCT) and the L-type amino acid transporter (LAT) families. LATs consist of a light chain (e.g. LAT2) and a heavy chain (CD98), which is essential for their cell surface expression and functionality. The specificity of Lat2 for thyroid hormones and their metabolites and its role in their transport was not fully clear. This fact motivated us to establish a cell system to elucidate the uptake of thyroid hormones and their metabolites by mouse Lat2. The coinjection of cRNA coding for Lat2 and CD98 into Xenopus laevis oocytes resulted in a markedly increased level of 3,3'-diiodo-L-thyronine (3,3'-T2) and to some extent also enhanced T3 transport. To gain insight into properties of thyroid hormones and their metabolites transported by Lat2, we inhibited 3,3'-T2 uptake by various iodothyronine derivatives. T1 and T2 derivatives as well as 2-aminobicyclo-[2, 2,1]-heptane-2-carboxylic acid strongly competed with 3,3'-T2 uptake. In addition, we performed T2 uptake measurements with the thyroid hormone-specific transporter MCT8. For both Lat2 and MCT8, Km values in a low micromolar range were calculated. We demonstrated that oocytes are a suitable system for thyroid hormone transport studies mediated by Lat2. Our data indicates that Lat2 compared to other thyroid hormone transporters prefers 3,3'-T2 as the substrate. Thus, Lat2 might contribute to the availability of thyroid hormone by importing and/or exporting 3,3'-T2, which is generated either by T3 inactivation or by rapid deiodinase 1-mediated rT3 degradation.
Ball,
3,5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro.
1997, Pubmed
Ball,
3,5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro.
1997,
Pubmed
Bernal,
Thyroid hormones and brain development.
1995,
Pubmed
Braun,
Aminoaciduria, but normal thyroid hormone levels and signalling, in mice lacking the amino acid and thyroid hormone transporter Slc7a8.
2011,
Pubmed
Braun,
Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells.
2011,
Pubmed
Brown,
A tribute to the Xenopus laevis oocyte and egg.
2004,
Pubmed
,
Xenbase
Bröer,
Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
2001,
Pubmed
,
Xenbase
Bröer,
Discrimination of two amino acid transport activities in 4F2 heavy chain- expressing Xenopus laevis oocytes.
1998,
Pubmed
,
Xenbase
Christensen,
A bicyclic amino acid to improve discriminations among transport systems.
1969,
Pubmed
Friesema,
Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
2001,
Pubmed
,
Xenbase
Friesema,
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter.
2003,
Pubmed
,
Xenbase
Jonas,
3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male diet-induced obese mice.
2015,
Pubmed
Khunweeraphong,
Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
2012,
Pubmed
Kinne,
Primary and secondary thyroid hormone transporters.
2011,
Pubmed
Kinne,
Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8.
2010,
Pubmed
Lanni,
Specific binding sites for 3,3'-diiodo-L-thyronine (3,3'-T2) in rat liver mitochondria.
1994,
Pubmed
Lehmphul,
Detection of 3,5-diiodothyronine in sera of patients with altered thyroid status using a new monoclonal antibody-based chemiluminescence immunoassay.
2014,
Pubmed
Meier,
Activation of system L heterodimeric amino acid exchangers by intracellular substrates.
2002,
Pubmed
,
Xenbase
Mendoza,
3,5-T2 is an alternative ligand for the thyroid hormone receptor β1.
2013,
Pubmed
Moreno,
Metabolic effects of thyroid hormone derivatives.
2008,
Pubmed
Morimoto,
Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters.
2008,
Pubmed
,
Xenbase
Núñez,
Cerebral cortex hyperthyroidism of newborn mct8-deficient mice transiently suppressed by lat2 inactivation.
2014,
Pubmed
Padron,
Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues.
2014,
Pubmed
Pietzner,
Translating pharmacological findings from hypothyroid rodents to euthyroid humans: is there a functional role of endogenous 3,5-T2?
2015,
Pubmed
Pineda,
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
1999,
Pubmed
,
Xenbase
Pizzagalli,
Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter.
2002,
Pubmed
,
Xenbase
Rossier,
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
1999,
Pubmed
,
Xenbase
Schmidt-Rose,
Transmembrane topology of a CLC chloride channel.
1997,
Pubmed
Segawa,
Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity.
1999,
Pubmed
,
Xenbase
Silva,
Thyroid hormone control of thermogenesis and energy balance.
1995,
Pubmed
Tohyama,
Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier.
2004,
Pubmed
Visser,
Minireview: thyroid hormone transporters: the knowns and the unknowns.
2011,
Pubmed
Wirth,
Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome.
2009,
Pubmed
Zoeller,
Thyroid hormone, brain development, and the environment.
2002,
Pubmed
